Belite Bio (BLTE) EV to EBITDA (2022 - 2026)

Belite Bio (BLTE) EV to EBITDA (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBITDA
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -852,542.90
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -155,086.11
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -34,369.83
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 680.60
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 24.45
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 16.40
7 Belite Bio 61.40 Bn 61.40 Bn - -3.48
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 43.50
9 Revolution Medicines 37.37 Bn 37.37 Bn - -26.95
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 43.97

Historic Data

Download Data
DateValue
Jul 23, 2026 -3.55
Jul 22, 2026 -3.57
Jul 21, 2026 -3.65
Jul 20, 2026 -3.47
Jul 17, 2026 -3.41
Jul 16, 2026 -3.42
Jul 15, 2026 -3.39
Jul 14, 2026 -3.33
Jul 13, 2026 -3.34
Jul 10, 2026 -3.39
Jul 9, 2026 -3.48
Jul 8, 2026 -3.46
Jul 7, 2026 -3.58
Jul 6, 2026 -3.49
Jul 2, 2026 -3.33
Jul 1, 2026 -3.23
Jun 30, 2026 -3.49
Jun 29, 2026 -3.51
Jun 26, 2026 -3.37
Jun 25, 2026 -3.40